These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25501685)

  • 1. Understanding variation in disease risk: the elusive concept of frailty.
    Aalen OO; Valberg M; Grotmol T; Tretli S
    Int J Epidemiol; 2015 Aug; 44(4):1408-21. PubMed ID: 25501685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biodemography of variation in human frailty.
    Weiss KM
    Demography; 1990 May; 27(2):185-206. PubMed ID: 2332085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: Frailty and heterogeneity in epidemiological studies.
    Moolgavkar SH
    Int J Epidemiol; 2015 Aug; 44(4):1425-6. PubMed ID: 25878216
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: Frailty and cancer.
    Peto J
    Int J Epidemiol; 2015 Aug; 44(4):1423-4. PubMed ID: 25842266
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: Age and frailty-not quite the same thing.
    Mathews JD; Hopper JL
    Int J Epidemiol; 2015 Aug; 44(4):1421-3. PubMed ID: 25855711
    [No Abstract]   [Full Text] [Related]  

  • 6. Nested frailty models using maximum penalized likelihood estimation.
    Rondeau V; Filleul L; Joly P
    Stat Med; 2006 Dec; 25(23):4036-52. PubMed ID: 16463308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates.
    Keiding N; Andersen PK; Klein JP
    Stat Med; 1997 Jan 15-Feb 15; 16(1-3):215-24. PubMed ID: 9004393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of testicular cancer data using a frailty model with familial dependence.
    Moger TA; Aalen OO; Heimdal K; Gjessing HK
    Stat Med; 2004 Feb; 23(4):617-32. PubMed ID: 14755393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating hospital heterogeneity with a competing risks frailty model.
    Rueten-Budde AJ; Putter H; Fiocco M
    Stat Med; 2019 Jan; 38(2):269-288. PubMed ID: 30338563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hierarchical frailty model for familial testicular germ-cell tumors.
    Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Aalen OO
    Am J Epidemiol; 2014 Feb; 179(4):499-506. PubMed ID: 24219863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proportional hazards models with frailties and random effects.
    O'Quigley J; Stare J
    Stat Med; 2002 Nov; 21(21):3219-33. PubMed ID: 12375300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor dormancy and frailty models: A novel approach.
    Rancoita PM; Valberg M; Demicheli R; Biganzoli E; Di Serio C
    Biometrics; 2017 Mar; 73(1):260-270. PubMed ID: 27398936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of inter-individual heterogeneity into the multistage carcinogenesis model: approach to the analysis of cancer incidence data.
    Izumi S; Ohtaki M
    Biom J; 2007 Aug; 49(4):539-50. PubMed ID: 17722193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalizations and applications of frailty models for survival and event data.
    Pickles A; Crouchley R
    Stat Methods Med Res; 1994; 3(3):263-78. PubMed ID: 7820295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parametric conditional frailty models for recurrent cardiovascular events in the lipid study.
    Cui J; Forbes A; Kirby A; Marschner I; Simes J; West M; Tonkin A
    Clin Trials; 2008; 5(6):565-74. PubMed ID: 19029205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authors' response: Understanding variation in disease risk.
    Aalen OO; Valberg M; Grotmol T; Tretli S
    Int J Epidemiol; 2015 Aug; 44(4):1426-8. PubMed ID: 25842265
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methodology for analyzing censored correlated data: application of marginal and frailty approaches in human genetics. The European Community Alport Syndrome Concerted Action Group (ECASCA)].
    Albert I; Jais JP
    Rev Epidemiol Sante Publique; 1999 Dec; 47(6):545-54. PubMed ID: 10673588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic frailty models based on compound birth-death processes.
    Putter H; van Houwelingen HC
    Biostatistics; 2015 Jul; 16(3):550-64. PubMed ID: 25681608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of frailty in survival analysis.
    Aalen OO
    Stat Methods Med Res; 1994; 3(3):227-43. PubMed ID: 7820293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression with frailty in survival analysis.
    McGilchrist CA; Aisbett CW
    Biometrics; 1991 Jun; 47(2):461-6. PubMed ID: 1912255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.